Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 safety and immunogenicity study of Sabin trivalent oral polio vaccine in previously OPV-vaccinated adults
2015-003324-32Phase 4Completed
- Sponsor
- University of Antwerp
- Start
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of trivalent oral poliovirus vaccine in poliomyelitis, sponsored by University of Antwerp. Primary endpoints: Serious adverse events, Severe adverse events and 1 more. Started Aug 2015; status: completed.
02
Drugs
trivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2015-003324-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003324-32.